Mucosal Immunity and Sublingual Immunotherapy in Respiratory Disorders

• Mucosal Immunity and Sublingual Immunotherapy in Respiratory Disorders, Nerin N. Bahceciler
  Volume 2012 (2012), Article ID 725719, 2 pages
• Comment on “Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review”, George F. Kroker, Vijay K. Sabnis, Mary S. Morris, and James C. Thompson
  Volume 2012 (2012), Article ID 969861, 2 pages
• Can Serum-Specific IgE/Total IgE Ratio Predict Clinical Response to Allergen-Specific Immunotherapy in Children Monosensitized to House Dust Mite?, Gulbin Bingol Karakoc, Mustafa Yilmaz, Derya Ufuk Altintaş, and Seval Güneşer Kendirli
  Volume 2012 (2012), Article ID 694094, 5 pages
• Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review, Takashi Fujimura, Yoshitaka Okamoto, and Masaru Taniguchi
  Volume 2012 (2012), Article ID 381737, 9 pages
• Quality of Life Improvement with Sublingual Immunotherapy: A Prospective Study of Efficacy, Mary S. Morris, Amanda Lowery, Demetrios S. Theodoropoulos, R. Daniel Duquette, and David L. Morris
  Volume 2012 (2012), Article ID 253879, 6 pages
• A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis, Roberta Alesina, Massimo Milani, and Silvia Pecora
  Volume 2012 (2012), Article ID 673502, 6 pages
• Development of Mucosal Immunity in Children: A Rationale for Sublingual Immunotherapy?, Aleksandra Szczawinska-Poplonyk
  Volume 2012 (2012), Article ID 492761, 7 pages